Market Research Logo

Global Cardiopulmonary Autotransfusion Systems Market 2016-2020

About the Cardiopulmonary Autotransfusion Systems Market

Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac operations. This procedure is processed in autotransfusion systems that help minimize blood loss by collecting and filtering the RBCs, and reinfusing the blood into an individual. Autotransfusion is an autologous technology involving the retransfusion of a person's own blood, which increases the need for traditional centrifuge devices for separating the RBCs from the blood. Advances in technology have led companies to integrate ultrafiltration technique for blood collection. For instance, Advancis Surgical's ultrafiltration-based HemoSep system can improve patient recovery time by filtering inflammatory molecules, preserving normal clotting function, and maintaining platelet populations.

Technavio’s analysts forecast the global cardiopulmonary autotransfusion systems to grow at a CAGR of 1.91% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiopulmonary autotransfusion systems for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of cardiopulmonary autotransfusion systems globally. These systems help reduce the risk of infections that can occur due to the use of allogenic blood.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Cardiopulmonary Autotransfusion Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Advancis Surgical
  • Fresenius Kabi
  • Haemonetics
  • LivaNova
  • Medtronic
  • Terumo
Other prominent vendors
  • Atrium Medical
  • Global Blood Resources
  • Redax
  • Sarstedt
  • Stryker
Market driver
  • Rise in cardiac surgeries
  • For a full, detailed list, view our report
Market challenge
  • Limitations of autotransfusion technology
  • For a full, detailed list, view our report
Market trend
  • Development of ultrafiltration systems
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Cardiopulmonary Autotransfusion Systems Market 2016-2020

Technavio recognizes the following companies as the key players in the global cardiopulmonary autotransfusion systems market: Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, and Terumo.

Other Prominent Vendors in the market are: Atrium Medical, Global Blood Resources, Redax, Sarstedt, and Stryker.

Commenting on the report, an analyst from Technavio’s team said: “One trend augmenting the growth of this market is the development of ultrafiltration systems. At present, medical facilities are using three types of ultrafiltration techniques during cardiac surgeries - conventional ultrafiltration, modified ultrafiltration, and zero balance ultrafiltration. Additionally, some vendors are also focusing on developing modified ultrafiltration-based systems. For instance, Global Blood Resources and Advancis Surgical have developed ultrafiltration technique-based HemoBag blood salvage device and HemoSep system, respectively.”

According to the report, one driver that will incite growth in this market is the complications associated with allogenic blood transfusion. Cardiac surgeries are complex and involve the loss of a significant amount of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for a significant volume of blood supply, which depends on the complexity of the surgery.

Further, the report states that the use of allogenic blood transfusion will inhibit the possibilities for growth in this market. Autotransfusion technology was developed to replace allogenic blood transfusion that has many adverse effects. However, many hospitals and ASCs worldwide, particularly in countries in APAC and developing economies such as Brazil, Mexico, India, and China, are still using allogenic blood transfusion despite its known complications. Many people in these countries are unaware of autotransfusion technology and associated systems and benefits.

Companies Mentioned

Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources, Redax, Sarstedt, and Stryker.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Cardiopulmonary diseases: An overview
      • Table Types of cardiopulmonary diseases
    • Cardiopulmonary autotransfusion systems: An overview
    • Role of autotransfusion in cardiac surgeries
      • Table Peri-operative period and its different stages
      • Table History of autotransfusion
      • Table Autotransfusion systems for other surgeries
    • Cardiopulmonary autotransfusion process
      • Table Process of autotransfusion
      • Table Components of cardiopulmonary autotransfusion system
  • Classification of medical devices
  • Cost analysis
    • Cost analysis of cardiopulmonary autotransfusion systems
      • Table Cost analysis of cardiopulmonary autotransfusion
      • Table Cost breakdown of CABG surgery and cardiopulmonary autotransfusion 2015
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global cardiopulmonary autotransfusion systems market 2015-2020 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by end-user
    • Table Global cardiopulmonary autotransfusion systems market segmentation by end-user 2015
    • Hospitals
    • ASCs
  • Geographical segmentation
    • Table Global cardiopulmonary autotransfusion systems market segmentation by geography 2015
    • Table Global cardiopulmonary autotransfusion systems market segmentation by geography 2020
    • Table Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020
    • Table Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020 ($ millions)
    • Cardiopulmonary autotransfusion systems market in Americas
      • Table Cardiopulmonary autotransfusion systems market in Americas 2015-2020 ($ millions)
      • Table Comparison of US healthcare system: Before and after reforms
      • Table Implements amended in ACA
    • Cardiopulmonary autotransfusion systems market in EMEA
      • Table Number of coronary bypass surgeries per 100,000 people in Europe 2013
      • Table Cardiopulmonary autotransfusion systems market in EMEA 2015-2020 ($ millions)
    • Cardiopulmonary autotransfusion systems market in APAC
      • Table Cardiopulmonary autotransfusion systems market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Rise in cardiac surgeries
    • Complications of allogenic blood transfusion
    • Advances in autotransfusion technology
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Limitations of autotransfusion technology
    • Use of allogenic blood transfusion
    • Stringent regulatory framework and medical policies
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Development of ultrafiltration systems
    • Significant opportunities in emerging countries
    • Public awareness
  • Vendor landscape
    • Competitive scenario
  • Major vendors
    • Advancis Surgical
      • Table Advancis Surgical: Key takeaways
    • Fresenius Kabi
      • Table Fresenius Kabi: Key products
      • Table Fresenius Kabi: Key takeaways
    • Haemonetics
      • Table Haemonetics: Product segmentation by revenue FY2016
      • Table Haemonetics: Product segmentation by revenue 2015 and FY2016 ($ millions)
      • Table Haemonetics: Key takeaways
    • LivaNova
      • Table LivaNova: Key products
      • Table LivaNova: Revenue of cardiac surgery segment by geographical segmentation 2015
      • Table LivaNova: Key takeaways
    • Medtronic
      • Table Medtronic: Key product
      • Table Medtronic: Key takeaways
    • Terumo
      • Table Terumo: Key product
      • Table Terumo: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report